By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Teijin Pharma 

1-1, Uchisaiwaicho 2-chome, Chiyoda-ku

Tokyo    100-8585  Japan
Phone: 81-42-581-4321 Fax:



Company News
Teijin Pharma’s FEBURIC (Febuxostat) Approved As Indication For Cancer Chemotherapy-Induced Hyperuricemia 5/23/2016 12:42:52 PM
Teijin Pharma To Co-market New Anti-inflammatory Analgesic Patch Formulation 2/1/2016 9:33:09 AM
Teijin Pharma To Start Rental Service For SLEEPMATE 10 Continuous Positive Airway Pressure Device 1/29/2016 8:48:48 AM
Teijin Pharma Launches Patient-information Sharing System For Integrated Community-care Support Businesses 11/10/2015 10:13:31 AM
Teijin Pharma Starts Operation Of New R&D Center To Accelerate Material And Pharmaceutical Integrated Development 10/2/2015 9:38:13 AM
Teijin Pharma To Collaborate With Peptidream In Peptide Discovery 9/28/2015 9:59:20 AM
Teijin Pharma To Launch Small 45mg MUCOSOLVAN? L Expectorant Tablet In Japan 7/2/2015 8:42:27 AM
New Indication For Teijin Pharma’s Febuxostat In Europe 6/30/2015 2:50:41 PM
Teijin Pharma To Establish New R&D Center To Accelerate Integrated Pharmaceutical Development 10/6/2014 8:08:52 AM
Teijin Pharma To Develop Sheet-Type Fibrin Sealant For Surgical Operations 6/20/2014 8:50:01 AM